Pharmaceutical

Filter

Current filters:

None

Popular Filters

82 to 106 of 7206 results

EC withdraws investigation of UK’s Patent Box scheme

EC withdraws investigation of UK’s Patent Box scheme

17-02-2015

The European Commission has decided to withdraw its investigation into the UK government's Patent Box…

LegalPharmaceuticalUKUK governmentUnited Kingdom

Sprout Pharmaceuticals resubmits flibanserin to the FDA for women's hypoactive sexual desire disorder

Sprout Pharmaceuticals resubmits flibanserin to the FDA for women's hypoactive sexual desire disorder

17-02-2015

Privately-held US sexual health specialists Sprout Pharmaceuticals has resubmitted its New Drug Application…

flibanserinPharmaceuticalRegulationSprout PharmaceuticalsUSAWomen's Health

Insomnia drug market set to take major hit to 2016, with only partial recovery by 2023

Insomnia drug market set to take major hit to 2016, with only partial recovery by 2023

17-02-2015

The insomnia drug market is set to fall rapidly by 2016 but will partially recover by 2023, says research…

BelsomraLunestaMarkets & MarketingNeurologicalPatentsPatents & Trade marksPharmaceutical

FDA conference highlights: Agency focuses on pediatric therapies to treat rare diseases

FDA conference highlights: Agency focuses on pediatric therapies to treat rare diseases

17-02-2015

In a monthly FDA-focused blog published exclusively by The Pharma Letter, Dr Nicola Davies looks the…

FDAPharmaceuticalPharmacologyRegulationUSA

Takeda motesanib fails to meet primary endpoint in Ph III NSCLC study

Takeda motesanib fails to meet primary endpoint in Ph III NSCLC study

17-02-2015

In a second research negative this month, Japan’s largest drugmaker Takeda Pharmaceutical has today…

JapanmotesanibOncologyPharmaceuticalResearchTakeda Pharmaceutical

Jack Bailey to replace Deirdre Connelly as US pharma head at GSK

Jack Bailey to replace Deirdre Connelly as US pharma head at GSK

17-02-2015

UK pharma major GlaxoSmithKline has named Jack Bailey as president of its US pharma unit.

BoardroomGSKPharmaceuticalUnited StatesUSA

Fresenius Kabi sells German oncology compounding business

Fresenius Kabi sells German oncology compounding business

17-02-2015

Fresenius Kabi, a unit of the Germany-headquartered Fresenius Group, has sold its German subsidiary CFL…

CFLFreseniusFresenius KabiGermanyMergers & AcquisitionsNewCo PharmaOncologyPharmaceutical

Overview of Mexico’s pharmaceutical market

Overview of Mexico’s pharmaceutical market

17-02-2015

The improving regulatory environment and the increasing foreign direct investment make Mexico's pharmaceutical…

EspicomHealthcareMarkets & MarketingMexicoPharmaceutical

Alzheimer’s Research UK launches £30m Drug Discovery Alliance

Alzheimer’s Research UK launches £30m Drug Discovery Alliance

16-02-2015

Dementia research charity Alzheimer’s Research UK has announced a £30 million ($46 million) Drug Discovery…

Aging-associated diseasesNeurologicalPharmaceuticalResearchUK

Pharma pricing regulation puts Spain 15% lower than Eurozone average

Pharma pricing regulation puts Spain 15% lower than Eurozone average

16-02-2015

The average price per standard unit of medicine in Spain was 15% lower than the average of Eurozone countries…

EuropePharmaceuticalPharmaceutical industryPricingSpain

Sanofi could name Bayer's Olivier Brandicourt as new chief executive, sources say

Sanofi could name Bayer's Olivier Brandicourt as new chief executive, sources say

16-02-2015

Sources say that Olivier Brandicourt, the current head of healthcare at German drug major Bayer, is the…

BayerFranceManagementPharmaceuticalSanofi

In 2014, Finland’s pharma market saw steady development

16-02-2015

Last year, the pharmacy and hospital sectors of the Finnish pharmaceutical market grew relatively steadily,…

FinlandMarkets & MarketingPharmaceuticalPricing

Access to Medicine Foundation launches its 2014 report at European Parliament

Access to Medicine Foundation launches its 2014 report at European Parliament

16-02-2015

The 2014 Access to Medicine Foundation presented its 2014 report at the European Parliament, showing…

Business FinanceEFPIAEuropePharmaceuticalPricing

Study finds HRT increases the risk of ovarian cancer

16-02-2015

Research by the University of Oxford, published in the prestigious medical magazine The Lancet, found…

PharmaceuticalResearchWomen's Health

Novartis' heart failure drug LCZ696 granted FDA priority review

Novartis' heart failure drug LCZ696 granted FDA priority review

14-02-2015

The US Food and Drug Administration has granted priority review designation for combination pill LCZ696…

Cardio-vascularLCZ696NovartisPharmaceuticalRegulationsacubitrilUSAvalsartan

Bristol-Myers Squibb gives full responsibility for Erbitux in Japan to Merck

Bristol-Myers Squibb gives full responsibility for Erbitux in Japan to Merck

13-02-2015

German pharmaceuticals and chemicals major Merck KGaA is to end the co-promotion of Erbitux (cetuximab)…

Bristol-Myers SquibbErbituxJapanLicensingMerck & CoOncologyPharmaceutical

Eisai's lenvatinib shows statistically-significant progression-free survival in Ph III trial

Eisai's lenvatinib shows statistically-significant progression-free survival in Ph III trial

13-02-2015

Japanese drug major Eisai has published results of its SELECT Phase III study, showing its lenvatinib…

EisaiHealthJapanlenvatinibPharmaceuticalWeakness

Vaccines a $25.5 billion business in 2014; report

Vaccines a $25.5 billion business in 2014; report

13-02-2015

Vaccines are a big business, and a growing business, says health care market researcher Kalorama Information,…

GlaxoSmithKlineMarkets & MarketingMerck & CoNovartisPfizerPharmaceuticalSanofiVaccines

New Zealand’s PHARMAC calls for information on anti-diabetic agents

New Zealand’s PHARMAC calls for information on anti-diabetic agents

12-02-2015

New Zealand’s Pharmaceutical Management Agency, PHARMAC, today revealed it is interested in receiving…

DiabetesFinancialHealthcareNew ZealandPharmaceutical

Recordati's 2014 earnings up 20%

Recordati's 2014 earnings up 20%

12-02-2015

Italian pharma company Recordati saw earnings for 2014 soar by 20%, and is aiming to hit 1 billion euros…

FinancialGenerally Accepted Accounting PrinciplesItalyPharmaceuticalRecordati

82 to 106 of 7206 results

COMPANY SPOTLIGHT

Menarini

Back to top